neobookRx
DrugsLevel 4 LocalisationS0LOZEML

2,4-Dichlorobenzyl Alcohol/ Amylmetacresol [Discontinued in SA Market]

CombinationAntiseptic, Analgesic

Indications

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


  • Minor mouth and throat infections

Cautions

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


Contraindications

  • Hypersensitivity to the active ingredients or any of the excipients in this combination product

Cautions

  • Pregnancy
  • Breastfeeding
  • Children < 6 years
  • Fructose intolerance
  • Glucose-galactose malabsorption
  • Sucrose-isomaltose insufficiency

Adult dosage

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


Forms avail. in SA and covered in this monograph: loz

Symptomatic relief of minor mouth and throat infections
Relief of cough associated with colds and allergies

2,4-Dichlorobenzyl Alcohol/ Amylmetacresol
1.2/0.6 (mg)

  • Oral (loz): 1 loz, 2-3hrly; Max: 12 loz/24hrs

Paediatric dosage

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


Paed. forms avail. in SA and covered in this monograph: loz

Symptomatic relief of minor mouth and throat infections
Cough associated with colds and allergies

2,4-Dichlorobenzyl Alcohol/ Amylmetacresol
1.2/0.6 (mg)

  • Younger than 12 years: Not established for use
  • Older than 12 years: Oral (loz): 1 loz, 2-3hrly; Max: 8 loz/24hrs

Special populations

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


Pregnancy

  • Caution
  • There are no or limited amount of data from the use of amylmetacresol and 2,4-dichlorobenzyl alcohol. As with all medicines care should be taken when using this combination product in pregnancy

Breastfeeding

  • Caution
  • It is unknown whether 2,4-dichlorobenzyl alcohol, amylmetacresol or metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


Gastrointestinal Disorders

  • Glossodynia
  • Oral discomfort

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity

Interactions

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


No known significant interactions

Mechanism of action

Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).

The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.


2,4-Dichlorobenzyl alcohol and amylmetacresol have antiseptic properties.

Dosage forms

  • Lozenge

References

1. https://drive.google.com/drive/folders/1Sd97jCRW7uRhQs0cZatelibZR4oZBkEB (23/07/2010_Reckitt_Strepsils loz) 2. https://www.medicines.org.uk/emc/medicine/23391(07/04/2017_Reckitt Benckiser_Strepsils_loz) 3. NAPOS The Drug Database for Acute Porphyria: Amylmetacresol, Dichlorobenzyl alcohol; Accessed online 28 Jan 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s1.php?l=gbr] 4. South African Institute for Drug-Free Sport; Strepsils; Accessed online 04 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/]

Brands & products

0 products · cached snapshot
Trade names (1)
  • Strepsils

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 16651 · updated 9/21/2023